- MyIllumina
- Tools
AutoLoader 2.x
| System: | iScan, HiScanSQ |
|---|---|
| Technology: | BeadArray |
| Assay: | GoldenGate Genotyping Assay, Direct Hybridization Assay, Infinium DNA Analysis Assay, Whole-Genome DASL HT Assay |
| Applications: | Custom Genotyping, Cytogenetic Analysis, Focused Genotyping, Linkage Analysis, Whole-Genome Genotyping and Copy Number Analysis, Sequencing-Based Methylation Analysis, FFPE Sample Analysis, Whole-Genome Gene Expression Analysis |
| Species: | Any |
| Contents: | 10 Carriers (Single Reader), 20 Carriers (Dual Reader), Five Hotels, Scanner and Robot Baseplates, Monitor Arm (up to 19" LCD) with Unobstructed Keyboard and Mouse Tray, Installation and On-site Training, AutoLoader 2.x Software, One-Year Standard Warranty |
For faster genomic analysis the AutoLoader 2.x provides walk-away BeadChip loading and scanning with the HiScanSQ or iScan Systems. With continuous unattended operation, and the ability to load one or two microarray Readers at a time, the AutoLoader 2.x improves assay efficiency while decreasing overall costs. In a dual scanner setup, automating BeadChip loading and scanning with the AutoLoader 2.x can lead to an output of up to 200 million genotypes per day.
Two input and two output stacks can accommodate up to 20 carriers at a time, which, at four BeadChips per carrier, means 80 BeadChips can be handled unattended. For peace of mind, automatic email alerts include an end-of-scan summary and any critical system messages.
- A customized Tecan liquid handling robot (which can be ordered from Illumina) can be included with the system to automate sample preparation for even higher throughput
- The AutoLoader 2.x is integrated with Illumina's Laboratory Information Mangement System (LIMS) and iScan Control System software
The AutoLoader 2.x is available as a Single-Scanner or Dual-Scanner package to support one or two microarray Readers. Packages are also available to upgrade the AutoLoader or AutoLoader2 to the Single or Dual AutoLoader 2.x.
Order Information
At Illumina, our goal is to apply innovative technologies and revolutionary assays to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. These studies will help make the realization of personalized medicine possible. With such rapid advances in technology taking place, it is mission critical to have solutions that are not only innovative, but flexible, scalable, and complete with industry-leading support and service. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and prioritizing the needs of its customers, we strive to meet this challenge. Illumina's innovative, array-based solutions for DNA, RNA, and protein analysis serve as tools for disease research, drug development, and the development of molecular tests in the clinic.